Kailera Therapeutics KLRA
NASDAQ KLRA
$13.27 +0.06 (+0.45%)
At close: Nov 13, 2026 · 4:00 PM EST

Kailera Therapeutics (KLRA) Assets (2024 - 2026)

Updated

Kailera Therapeutics (KLRA) recorded Assets of $1.08 billion in Q3 2026, down 10.7% from the prior quarter.

Analysis

Kailera Therapeutics (KLRA) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Kailera Therapeutics reported Assets of $692.29 million, up 288.0% from FY2024.

  • Across earlier years, Assets came in at $178.45 million in FY2024.
  • Quarterly Assets has ranged from $178.45 million in Q4 2024 to $1.21 billion in Q2 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $1.21 billion (Q2 2026), $624.76 million (Q1 2026) and $692.29 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 197.43 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 147.68 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 205.00 Bn
10 Kailera Therapeutics 1.72 Bn -1.16 Bn - 1.08 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.08 Bn
Jun 30, 2026 1.21 Bn
Mar 31, 2026 624.76 Mn
Dec 31, 2025 692.29 Mn
Dec 31, 2024 178.45 Mn
API Access

Kailera Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=KLRA&period=max&api_key=YOUR_API_KEY